Amlodipine Besylate Tablet
Product Images NDC 65862-103

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 65862-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine Besylate versus Placebo)

A Kaplan-Meier curve comparing the event rate over time in months between Amlodipine and placebo groups. The graph shows lower event rates for the Amlodipine group with hazard ratio, confidence interval, and p-value displayed, alongside numbers at risk at various time points up to 24 months.*

FDA Label Image

Figure 2 (Effects on Primary Endpoint of Amlodipine Besylate versus Placebo across Sub-Groups)

A forest plot chart depicting hazard ratios with 95% confidence intervals comparing Amlodipine and placebo across various patient subgroups. The subgroups include overall patients, age groups (<65 and ≥65), gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The plot visually represents whether the data favors Amlodipine or placebo based on the hazard ratio scale from 0 to 2.*

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))

Label for Amlodipine Besylate Tablets USP 2.5 mg, a drug for further processing by Aurobindo Pharma Limited. The label specifies 30 tablets in the package, includes storage instructions, dispensing guidance, and distributor information for Aurobindo Pharma USA, Inc. It also shows the NDC 65862-101-30 and mentions the product is made in India.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

Label for Amlodipine Besylate Tablets, USP 5 mg by Aurobindo Pharma Limited. The label states the product is for prescription use (Rx only) and contains 30 tablets. Additional text includes storage instructions, dispensing requirements, and distributor information for Aurobindo Pharma USA, Inc. A barcode and an overprinting zone are also visible.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

Label for Amlodipine Besylate Tablets USP 10 mg, distributed by Aurobindo Pharma USA, Inc. The label indicates a package of 30 tablets with storage instructions and dispensing information. It includes the NDC 65862-103-30 and manufacturing origin as India by Aurobindo Pharma Limited.*

FDA Label Image

Chemical Structure (Amlodipine Str)

Chemical structure of Amlodipine Besylate, showing the molecular arrangement including chlorophenyl ring, dihydropyridine ring with substituents, and the besylate moiety (C7H8O3S).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.